Both MAPK and NF-κB are key signaling pathways responsible for inflammation in the development of AS and NAFLD (Hopkins, 2013; Hernández-Aquino and Muriel, 2018). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.